Successful treatment with nivolumab in a patient with unresectable oral squamous cell carcinoma following ineffective chemoradiotherapy
Key clinical message Nivolumab has been clinically successful in prolonging the overall survival of patients with recurrent and metastatic head and neck cancer, complete remission is rare. Synergistic combinations of immunotherapy and conventional cancer treatments, such as radiotherapy or chemother...
Main Authors: | Katsuhisa Sekido, Shuichi Imaue, Hidetake Tachinami, Kei Tomihara, Norihito Naruto, Kentaro Yamagishi, Atsushi Ikeda, Kumiko Fujiwara, Makoto Noguchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.8219 |
Similar Items
-
Durable complete response to immunotherapy with anti‐PD‐1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report
by: Katsuhisa Sekido, et al.
Published: (2021-09-01) -
Treatment of severe micrognathia in an adult with distraction osteogenesis: A case report
by: Katsuhisa Sekido, et al.
Published: (2023-06-01) -
Central mucoepidermoid carcinoma of the maxilla developing from a calcifying odontogenic cyst: A rare case report
by: Megumi Isshiki‐Murakami, et al.
Published: (2021-10-01) -
Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review
by: Ryota Mori, et al.
Published: (2022-05-01) -
Case Report: Complete Remission of a Patient With Metastatic Gastric Cancer Treated With Nivolumab Combined With Chemotherapy After Palliative Surgery
by: Peilin Dai, et al.
Published: (2022-06-01)